DIANA GONG’s practice focuses on commercial transactions, regulatory and compliance matters in the life sciences industry. She represents multinational pharmaceutical companies and their Chinese subsidiaries as well as Chinese biotechnology companies on matters in connection with their M&A transactions, licensing transactions, clinical trials, manufacturing, marketing authorization approval, importation/exportation, distribution, and promotional/advertising activities.
Prior to joining Sidley, Diana was an associate with another international law firm in its Silicon Valley office, representing private equity sponsors and venture capital investors in their asset management.
Diana received her J.D. from the University of Southern California in 2020 and her LL.M. from the University of California, Berkeley in 2015. She also earned an LL.B. from Peking University in 2014.
Diana is a native Mandarin speaker and is fluent in English.
This is available in:
- English
- 中文
Associate
Diana Gong
- Food, Drug and Medical Device Regulatory
- Healthcare
Experience
- Representative Matters
Recent experience includes*:
- Representing multinational pharmaceutical companies in their acquisitions and strategic collaborations in China;
- Advising multinational and Chinese pharmaceutical companies in connection with product approvals, clinical studies, marketing, promotion and distribution, market access, pricing and reimbursements in China;
- Representing emerging companies in their preferred stock financings.
*Includes matters completed prior joining Sidley.
Capabilities
SERVICES AND INDUSTRIES
Credentials
Admissions & Certifications
- California
Education
- University of Southern California Gould School of Law, J.D., 2020
- University of California, Berkeley School of Law, Master of Laws, 2015
- Peking University Law School, LL.B., 2014
Languages
- Chinese - Mandarin
- English